Insider Transactions in Q3 2022 at Aerovate Therapeutics, Inc. (AVTE)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 12
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
7,520
-86.0%
|
$127,840
$17.98 P/Share
|
Sep 12
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
7,520
+50.0%
|
$15,040
$2.14 P/Share
|
Sep 09
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
4,720
-98.14%
|
$84,960
$18.02 P/Share
|
Sep 09
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
4,720
+49.3%
|
$4,720
$1.94 P/Share
|
Sep 08
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
3,120
-89.92%
|
$56,160
$18.28 P/Share
|
Sep 08
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
3,120
+50.0%
|
$3,120
$1.74 P/Share
|
Sep 07
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
3,662
-50.05%
|
$65,916
$18.27 P/Share
|
Sep 07
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
8,220
+50.0%
|
$8,220
$1.74 P/Share
|
Sep 06
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
9,166
-78.49%
|
$164,988
$18.9 P/Share
|
Sep 06
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
9,166
+50.0%
|
$9,166
$1.74 P/Share
|
Sep 06
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$42,750
$19.0 P/Share
|
Sep 06
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
Aug 18
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$47,250
$21.18 P/Share
|
Aug 18
2022
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
Aug 16
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
21,000
-72.36%
|
$483,000
$23.28 P/Share
|
Aug 16
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
21,000
+50.0%
|
$21,000
$1.74 P/Share
|
Aug 11
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
1,347
-97.07%
|
$32,328
$24.22 P/Share
|
Aug 11
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
1,347
+50.0%
|
$1,347
$1.74 P/Share
|
Aug 10
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
12,720
-96.93%
|
$305,280
$24.27 P/Share
|
Aug 10
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
12,720
+50.0%
|
$12,720
$1.74 P/Share
|
Aug 09
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
8,700
-83.96%
|
$208,800
$24.18 P/Share
|
Aug 09
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
8,700
+50.0%
|
$8,700
$1.74 P/Share
|
Aug 08
2022
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
6,943
-78.73%
|
$166,632
$24.67 P/Share
|
Aug 08
2022
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
6,943
+50.0%
|
$6,943
$1.74 P/Share
|
Jul 15
2022
|
Atlas Venture Fund Xii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
310,388
-11.76%
|
-
|